Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01825603
Title ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed By Surgery
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Nebraska
Indications

gallbladder adenocarcinoma

pancreatic adenocarcinoma

bile duct adenocarcinoma

ampulla of Vater carcinoma

cholangiocarcinoma

Therapies

ADH-1 + Cisplatin + Gemcitabine

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.